Compare Abbott India with Orchid Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ORCHID PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

ORCHID PHARMA 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ORCHID PHARMA ABBOTT INDIA/
ORCHID PHARMA
 
P/E (TTM) x 47.3 -19.4 - View Chart
P/BV x 15.5 5.6 278.0% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 ABBOTT INDIA   ORCHID PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
ORCHID PHARMA
Sep-13
ABBOTT INDIA/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs8,834194 4,553.7%   
Low Rs5,45835 15,592.9%   
Sales per share (Unadj.) Rs1,731.1276.5 626.2%  
Earnings per share (Unadj.) Rs211.9-79.2 -267.5%  
Cash flow per share (Unadj.) Rs219.9-43.5 -506.1%  
Dividends per share (Unadj.) Rs65.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs945.253.9 1,752.4%  
Shares outstanding (eoy) m21.2570.45 30.2%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.10.4 996.7%   
Avg P/E ratio x33.7-1.4 -2,332.7%  
P/CF ratio (eoy) x32.5-2.6 -1,233.3%  
Price / Book Value ratio x7.62.1 356.1%  
Dividend payout %30.70-   
Avg Mkt Cap Rs m151,8488,067 1,882.4%   
No. of employees `0003.52.8 124.5%   
Total wages/salary Rs m4,3562,527 172.4%   
Avg. sales/employee Rs Th10,555.56,956.1 151.7%   
Avg. wages/employee Rs Th1,249.9902.5 138.5%   
Avg. net profit/employee Rs Th1,292.2-1,993.0 -64.8%   
INCOME DATA
Net Sales Rs m36,78619,477 188.9%  
Other income Rs m1,133407 278.2%   
Total revenues Rs m37,91919,884 190.7%   
Gross profit Rs m6,0471,103 548.5%  
Depreciation Rs m1692,519 6.7%   
Interest Rs m235,227 0.4%   
Profit before tax Rs m6,989-6,236 -112.1%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m2,485-125 -1,985.0%   
Profit after tax Rs m4,503-5,580 -80.7%  
Gross profit margin %16.45.7 290.4%  
Effective tax rate %35.62.0 1,771.3%   
Net profit margin %12.2-28.7 -42.7%  
BALANCE SHEET DATA
Current assets Rs m27,61011,014 250.7%   
Current liabilities Rs m8,56932,060 26.7%   
Net working cap to sales %51.8-108.1 -47.9%  
Current ratio x3.20.3 937.9%  
Inventory Days Days6095 63.5%  
Debtors Days Days2734 81.6%  
Net fixed assets Rs m1,05729,440 3.6%   
Share capital Rs m213705 30.2%   
"Free" reserves Rs m19,8732,043 972.9%   
Net worth Rs m20,0863,800 528.6%   
Long term debt Rs m09,018 0.0%   
Total assets Rs m29,40946,510 63.2%  
Interest coverage x311.6-0.2 -161,350.4%   
Debt to equity ratio x02.4 0.0%  
Sales to assets ratio x1.30.4 298.7%   
Return on assets %15.4-0.8 -2,024.8%  
Return on equity %22.4-146.9 -15.3%  
Return on capital %34.9-3.7 -934.6%  
Exports to sales %037.9 0.0%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs mNA7,378 0.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m3697,513 4.9%   
Fx outflow Rs m4,9185,649 87.1%   
Net fx Rs m-4,5491,865 -244.0%   
CASH FLOW
From Operations Rs m4,9911,682 296.8%  
From Investments Rs m-2,570-9,860 26.1%  
From Financial Activity Rs m-1,4286,644 -21.5%  
Net Cashflow Rs m993-1,535 -64.7%  

Share Holding

Indian Promoters % 0.0 32.3 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 4.6 171.7%  
FIIs % 0.1 3.3 3.0%  
ADR/GDR % 0.0 4.6 -  
Free float % 17.1 55.3 30.9%  
Shareholders   18,270 84,811 21.5%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   FDC  UNICHEM LAB  DR. REDDYS LAB  AJANTA PHARMA  ALEMBIC  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

6 Reasons Why Sensex Rallied 834 Points Today(Closing)

After staging a gap-up opening, Indian share markets extended gains as the session progressed and rallied nearly 2%, boosted by realty and finance stocks.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 19, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS